|CLDA shares are up to $20 from around |
$17.5 in the last several hours of trading,
Clinical Data showed net assets
of only 14M, but they are very
marginally profitable, at least
before buying Icoria.
I'll put it on my watch list and try to
post any interesting headlines I see
here on the pdgm/icor thread. I see this
too, a very small deal:
acquired Electa Lab s.r.l. in a cash transaction valued at approximately $1.8 million. Electa Lab, headquartered in Forli, Italy, is a leading worldwide supplier of Erythrocyte Sedimentation Rate ("ESR") instrumentation and related consumables, with annual sales of more than $3 million. Electa Lab has also developed proprietary technology for the safe decapping of blood collection tubes and is developing instruments and assays for the immunochemistry and coagulation markets. The acquisition will be accounted for as a purchase and is expected to be immediately accretive to Clinical Data's earnings.